A desensitization protocol for the mAb cetuximab

Maya R. Jerath; Mildred Kwan; Mily Kannarkat; Beloo Mirakhur; Lisa Carey; John Valgus; Thomas A.E. Platts-Mills; Teresa K. Tarrant

doi:10.1016/j.jaci.2008.09.046

A desensitization protocol for the mAb cetuximab

Maya R. Jerath, Mildred Kwan, Mily Kannarkat, Beloo Mirakhur, Lisa Carey, John Valgus, Thomas A.E. Platts-Mills, Teresa K. Tarrant

Division of Allergy & Immunology

Research output: Contribution to journal › Letter › peer-review

37 Scopus citations

Original language	English
Pages (from-to)	260-262
Number of pages	3
Journal	Journal of Allergy and Clinical Immunology
Volume	123
Issue number	1
DOIs	https://doi.org/10.1016/j.jaci.2008.09.046
State	Published - Jan 2009

Access to Document

10.1016/j.jaci.2008.09.046

Cite this

@article{2179e6843ffe4b42b57244af9434d598,

title = "A desensitization protocol for the mAb cetuximab",

author = "Jerath, {Maya R.} and Mildred Kwan and Mily Kannarkat and Beloo Mirakhur and Lisa Carey and John Valgus and Platts-Mills, {Thomas A.E.} and Tarrant, {Teresa K.}",

note = "Funding Information: Disclosure of potential conflict of interest: B. Mirakhur is employed by Bristol-Myers Squibb. T. A. E. Platts-Mills has served as a consultant for Dyson Vacuum Cleaners and Indoor Biotechnologies and has received research support from ImClone. T. K. Tarrant has received research support from the National Institute of Allergy and Infectious Diseases/National Institutes of Health and the American College of Rheumatology. The rest of the authors have declared that they have no conflict of interest. ",

year = "2009",

month = jan,

doi = "10.1016/j.jaci.2008.09.046",

language = "English",

volume = "123",

pages = "260--262",

journal = "Journal of Allergy and Clinical Immunology",

issn = "0091-6749",

number = "1",

}

TY - JOUR

T1 - A desensitization protocol for the mAb cetuximab

AU - Jerath, Maya R.

AU - Kwan, Mildred

AU - Kannarkat, Mily

AU - Mirakhur, Beloo

AU - Carey, Lisa

AU - Valgus, John

AU - Platts-Mills, Thomas A.E.

AU - Tarrant, Teresa K.

N1 - Funding Information: Disclosure of potential conflict of interest: B. Mirakhur is employed by Bristol-Myers Squibb. T. A. E. Platts-Mills has served as a consultant for Dyson Vacuum Cleaners and Indoor Biotechnologies and has received research support from ImClone. T. K. Tarrant has received research support from the National Institute of Allergy and Infectious Diseases/National Institutes of Health and the American College of Rheumatology. The rest of the authors have declared that they have no conflict of interest.

PY - 2009/1

Y1 - 2009/1

UR - http://www.scopus.com/inward/record.url?scp=58149117582&partnerID=8YFLogxK

U2 - 10.1016/j.jaci.2008.09.046

DO - 10.1016/j.jaci.2008.09.046

M3 - Letter

C2 - 19022494

AN - SCOPUS:58149117582

SN - 0091-6749

VL - 123

SP - 260

EP - 262

JO - Journal of Allergy and Clinical Immunology

JF - Journal of Allergy and Clinical Immunology

IS - 1

ER -

A desensitization protocol for the mAb cetuximab

Access to Document

Other files and links

Cite this